Results 261 to 270 of about 37,898 (281)
Some of the next articles are maybe not open access.
Co-morbidity (HFrEF and HFpEF): hypertension
2018Hypertensive heart disease is a major cause of heart failure (HF) and mortality. Hypertension precedes HF occurrence in 75% of cases, and carries a sixfold increase in HF risk as compared to non-hypertensive individuals. Most importantly, a minority of patients survive 5 years after the onset of hypertensive HF.
Francesco Paneni, Massimo Volpe
openaire +1 more source
Neue Therapiekonzepte der HfrEF
Kardiologie up2date, 2021Michael Böhm, Jan Wintrich, Amr Abdin
openaire +2 more sources
Dapagliflozin — a breakthrough in the search for drugs to treat HFrEF
Nature Reviews Cardiology, 2019Results from the DAPA-HF trial demonstrate that dapagliflozin therapy is associated with lower risk of worsening heart failure or cardiovascular death than placebo, regardless of the presence or absence of diabetes.
openaire +3 more sources
Comparison Chart: Some Drugs for HFrEF
The Medical Letter on Drugs and TherapeuticsComparison Chart: Some Drugs for ...
openaire +2 more sources
Promising findings for cell therapy in HFrEF
Nature Reviews Cardiology, 2023openaire +2 more sources
HFpEF vs. HFrEF: can microRNAs advance the diagnosis? [PDF]
European Journal of Heart Failure, 2015 Adriaan A. Voors +2 more
openaire +3 more sources